These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15187171)

  • 21. Validity of the ages and stages questionnaires in term and preterm infants.
    Schonhaut L; Armijo I; Schönstedt M; Alvarez J; Cordero M
    Pediatrics; 2013 May; 131(5):e1468-74. PubMed ID: 23629619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of 2-year-old children after early surgery for congenital heart disease on the Bayley Scales of Infant and Toddler Development, Third Edition.
    Long SH; Galea MP; Eldridge BJ; Harris SR
    Early Hum Dev; 2012 Aug; 88(8):603-7. PubMed ID: 22336496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation and adaptation of rapid neurodevelopmental assessment instrument for infants in Guatemala.
    Thompson L; Peñaloza RA; Stormfields K; Kooistra R; Valencia-Moscoso G; Muslima H; Khan NZ
    Child Care Health Dev; 2015 Nov; 41(6):1131-9. PubMed ID: 26250756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Second and Third Editions of the Bayley Scales in Children With Suspected Developmental Delay.
    Yi YG; Sung IY; Yuk JS
    Ann Rehabil Med; 2018 Apr; 42(2):313-320. PubMed ID: 29765885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-exposed infants and developmental outcome: effects of a home intervention and ongoing maternal drug use.
    Schuler ME; Nair P; Kettinger L
    Arch Pediatr Adolesc Med; 2003 Feb; 157(2):133-8. PubMed ID: 12580681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overestimating neurodevelopment using the Bayley-III after early complex cardiac surgery.
    Acton BV; Biggs WS; Creighton DE; Penner KA; Switzer HN; Thomas JH; Joffe AR; Robertson CM
    Pediatrics; 2011 Oct; 128(4):e794-800. PubMed ID: 21949148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for language delay after life-saving therapies in term-born infants.
    Clark BG; Acton BV; Alton GY; Joffe AR; Dinu IA; Robertson CM
    Cardiol Young; 2016 Oct; 26(7):1343-51. PubMed ID: 26707335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
    Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
    Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity and clinical utility of children development assessement using milestones reported by mothers.
    Mrozek-Budzyn D; Kiełtyka MA; Majewska R
    Przegl Epidemiol; 2014; 68(1):71-5, 153-5. PubMed ID: 25004635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent validity of the Ages and Stages Questionnaire and the Bayley Scales of Infant Development III in China.
    Yue A; Jiang Q; Wang B; Abbey C; Medina A; Shi Y; Rozelle S
    PLoS One; 2019; 14(9):e0221675. PubMed ID: 31487302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of a screening tool to evaluate gross motor function in HIV-infected infants.
    Hilburn N; Potterton J; Stewart A; Becker P
    AIDS Care; 2011 Dec; 23(12):1619-25. PubMed ID: 21732898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Child Development Inventory: A developmental outcome measure for follow-up of the high-risk infant.
    Doig KB; Macias MM; Saylor CF; Craver JR; Ingram PE
    J Pediatr; 1999 Sep; 135(3):358-62. PubMed ID: 10484803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using the Bayley-III to assess neurodevelopmental delay: which cut-off should be used?
    Johnson S; Moore T; Marlow N
    Pediatr Res; 2014 May; 75(5):670-4. PubMed ID: 24492622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the 1969 and 1993 standardizations of the Bayley Mental Scales of Infant Development for infants with Down's syndrome.
    Glenn SM; Cunningham CC; Dayus B
    J Intellect Disabil Res; 2001 Feb; 45(Pt 1):56-62. PubMed ID: 11168777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent validity of the Comprehensive Developmental Inventory for Infants and Toddlers with the Bayley Scales of Infant Development-II in preterm infants.
    Liao HF; Wang TM; Yao G; Lee WT
    J Formos Med Assoc; 2005 Oct; 104(10):731-7. PubMed ID: 16385375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ASQ3 and/or the Bayley-III to support clinicians' decision making.
    Mackin R; Ben Fadel N; Feberova J; Murray L; Nair A; Kuehn S; Barrowman N; Daboval T
    PLoS One; 2017; 12(2):e0170171. PubMed ID: 28151969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental outcome of drug-exposed children through 30 months: a comparison of Bayley and Bayley-II.
    Schuler ME; Nair P; Harrington D
    Psychol Assess; 2003 Sep; 15(3):435-8. PubMed ID: 14593844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the Ages and Stages Questionnaire and Bayley Scales of Infant Development-II in neurodevelopmental follow-up of extremely low birth weight infants.
    Woodward BJ; Papile LA; Lowe JR; Laadt VL; Shaffer ML; Montman R; Watterberg KL
    J Perinatol; 2011 Oct; 31(10):641-6. PubMed ID: 21311498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive validity of the Bayley, Third Edition at 2 years for intelligence quotient at 4 years in preterm infants.
    Bode MM; DʼEugenio DB; Mettelman BB; Gross SJ
    J Dev Behav Pediatr; 2014; 35(9):570-5. PubMed ID: 25370298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applying Dutch and US versions of the BSID-II in Dutch children born preterm leads to different outcomes.
    Westera JJ; Houtzager BA; Overdiek B; van Wassenaer AG
    Dev Med Child Neurol; 2008 Jun; 50(6):445-9. PubMed ID: 18459980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.